BioSpace News Archive

In the last few days, all attention in China is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV).

IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification, and interpretation of microorganisms and their role in human health, today announced the raise of $20 million in its Series B financing led by ARTIS Ventures and joined by Genesys Capital and others.

VADovations, Inc., a company developing miniaturized cardiac assist pumps offering best-in-class blood handling properties, high performance and low cost, today announces an agreement to license intellectual property from Mayo Clinic for endovascular deployment of VADovations’ novel cardiac assist pump for long-term use in patients suffering with heart failure.

Bluestar Genomics, a company developing innovative, data-driven, epigenomic approaches to comprehensive disease analysis and diagnostics, today announced the publication of a new study demonstrating the efficacy of their 5-hydroxymethylcytosine (5hmC) signal detection technology for its use in breast, lung, pancreatic, and prostate cancer

Biodesix, Inc. and Streck, Inc. today announced a Regulatory Cooperation Agreement that will further enable both companies in their pursuit of FDA approval for diagnostic testing services and specimen collection products.

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today a research collaboration with a Japanese biopharma company utilizing AgeX’s HLA-G-based immunotolerance UniverCyteTM technology platform for the engineering of hypoimmunogenic (universal) cells.

Polarean Imaging plc (AIM: POLX), a clinical stage medical imaging technology company developing a proprietary magnetic resonance imaging (MRI) drug-device combination, today announced positive top-line results from two pivotal Phase III clinical trials of the Company’s drug-device combination, which uses hyperpolarized 129Xenon gas MRI to visualize and quantify regional lung function.

In line with the firm’s corporate mission of delivering a “Beautiful and Better Life”, Proya Cosmetics Co., Ltd. (SHA: 603605) is contributing to the effort to control and prevent further expansion of the 2019 novel Coronavirus (2019-nCoV) epidemic during these critical days.

Winner from month-long contest honoring unsung heroes will receive a special care package from the award-winning actress

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced that independent researchers reported in a recent study that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex™ immunogene therapy, is a potential target and biomarker for thyroid carcinoma.